In HCC, similar to observations in melanoma, CCL11-expressing tumors demonstrate that IL-5/CCL11 co-stimulation effectively recruits tumor-associated eosinophils, potentially mediating both immune evasion and tumoricidal effects [19]. This evidence concerns the gene CCL11 and hepatocellular carcinoma.